logoalt Hacker News

rzmmmtoday at 5:43 AM3 repliesview on HN

I'm glad we have GLP-1, and I don't think there are really major side effects. But they are ineffective outside clinical trial setting for treating obesity.

It seems to be like treating alcoholism with disulfiram: it's a miracle in clinical trials but in the real world the patients just lower the doses or discontinue treatment after 1-2 years and go back to their old habits.


Replies

cthalupatoday at 8:40 AM

> But they are ineffective outside clinical trial setting for treating obesity.

This is one of the wildest claims I have ever seen on this website.

Would you claim insulin is ineffective outside of clinical trials for treating type 1 diabetes because people have to keep injecting it?

show 1 reply
JumpCrisscrosstoday at 6:21 AM

> they are ineffective outside clinical trial setting for treating obesity

This is totally false. I know a number of people who took GLP-1 to treat their obesity and then stopped and have stayed not obese.

show 2 replies
XorNottoday at 7:02 AM

It is not ineffective outside of clinical trials. All the evidence says that people gain some weight back after they discontinue treatment - which is not a lack of efficacy. But they also usually gain back less then they lost.

https://pmc.ncbi.nlm.nih.gov/articles/PMC12361690/

show 1 reply